Gapping up
In reaction to earnings/guidance:
- SNAP +45.6%, BILL +24.8%, PINS +12.6%, AMZN +12.2% (also increases price for Prime membership), U +12%, EGAN +10.4%, LESL +8.3%, NWSA +6.9%, SYNA +6.8%, SKX +6.8%, MWA +6.4%, EAF +6.1%, PCTY +5.8%, ENVA +5.7%, PYCR +4.5%, GPRO +4.3% (also announces $100 mln share buyback authorization), VIAV +4%, WERN +3.2%, NLOK +2.8%, HIG +2.5%, PFSI +2.2%, COLM +2.2%, MIME +2.1%, WWE +2%, BYD +1.5%, BECN +1.5%, CVCO +1%, ADNT +0.8%, BMY +0.7%
Other news:
- ORTX +10.5% (Announces Historic Agreement Making Libmeldy Available by NHS England for MLD Patients)
- ACIU +6% (preclinical data on the optimized formulation of its wholly-owned amyloid-beta vaccine program ACI-24 were published in the peer reviewed journal Brain Communications)
- CWT +2.9% (receives state approval to acquire assets of Valencia Mesa)
- NVAX +2.5% (receives provisional approval for NVX-CoV2373 in New Zealand)
- HLIT +1.8% (approves $100 mln share repurchase program)
- AXDX +1.4% (stock offering)
- DOGZ +1.3% (files for $250 mln mixed securities shelf offering)
- TSLA +1.2% (to construct cathode building at Texas Gigafactory according to Reuters)
- BALY +1% (forms special committee to evaluate Standard General acquisition proposal)
Analyst comments:
- GTLB +5.3% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
- JNCE +5.3% (upgraded to Outperform from Market Perform at Cowen)
- BJ +3.3% (upgraded to Buy from Hold at Deutsche Bank)